Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05938075Phase 1Completed
Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa
SARS-CoVSARS-CoV-2
PrincipalinvestigatorStart date: 2023-08-04

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Perinatal HIV Research Unit (PHRU)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nadine Rouphael, MD

Emory University

Moderately Similar
18 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Similarity Score30%

Samantha Siva, MMEDSc

HIV and other Infectious Diseases Research Unit (HIDRU)

Related
1 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Medical Research Council, South AfricaVaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score24%

Glenda Gray, MBChB, FC

Medical Research Council, South Africa

Related
1 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Medical Research Council, South AfricaVaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score24%

Ravindre Panchia, MBChB

Perinatal HIV Research Unit (PHRU)

Related
1 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Medical Research Council, South AfricaVaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score24%

Mbalizethu Mntambo, MBChB

HIV and other Infectious Diseases Research Unit (HIDRU)

Related
1 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Medical Research Council, South AfricaVaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score24%

lanjuan li

Shulan (Hangzhou) Hospital

Related
6 trials

Shared therapeutic areas:

SARS-CoV-2
Similarity Score15%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

SARS-CoV-2
Similarity Score15%

Saad Nseir, MD,PhD

University Hospital, Lille

Related
9 trials

Shared therapeutic areas:

SARS-CoV-2
Similarity Score15%

Walid Habre, MD, PhD

University of Geneva, Switzerland

Related
5 trials

Shared therapeutic areas:

SARS-CoV-2
Similarity Score15%

Lloyd Tran, PhD

Biomed Industries, Inc.

Related
6 trials

Shared therapeutic areas:

SARS-CoV-2
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05938075Phase 1PrincipalInvestigator

Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa

SARS-CoVSARS-CoV-2
Completed

All 1 trials loaded